Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
ADMA Biologics Announces Pricing Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Saturday, June 9, 2018 2:00 AM EDT
ADMA Biologics, Inc. announced today the pricing of its previously announced underwritten public offering of 8,368,200 shares of its common stock at a public offering price of $4.78 per share.
In this article: ADMA
ADMA Biologics: Almost Ready To Run Between The Toes Of Giants
Article By:
Simon Daly
Tuesday, March 6, 2018 10:27 PM EDT
ADMA’s lead product candidate has positive data, positioned for high unmet medical need. The burden of lifting regulatory hold is lower than might be perceived by investors at present.
In this article: ADMA
ADMA Biologics Announces Pricing Of Follow-On Offering
Article By:
NASDAQ GlobeNewswire
Thursday, November 9, 2017 11:27 AM EDT
ADMA Biologics, Inc. today announced the pricing of an underwritten public offering of approximately 17.0 million shares of its common stock at a public offering price of $2.15 per share, representing gross proceeds of approximately $36.5 million.
In this article: ADMA
Seven Biotech Names On The Upswing: 2016 Small-Cap Biotech Watchlist Update
Article By:
The Life Sciences Report
Wednesday, March 9, 2016 5:47 PM EDT
Biotech stocks—and the stock market in general—took a dive at the beginning of 2016, headed down on macroeconomic factors such as financial instability in China.
In this article: SGYP, CRMD, ORMP, SRNE, ARRY, PTIE, AGEN, GALE, PPHM, EVOK, ADMA, AKBA, KPTI, VSTM, AST, RXDX, AGTC, WVE, FATE, FLKS, PIRS, ABEO